IRIS
IASEVOLI, FELICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.828
EU - Europa 3.695
NA - Nord America 3.341
SA - Sud America 779
AF - Africa 146
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.182
SG - Singapore 2.547
RU - Federazione Russa 1.820
CN - Cina 1.169
IT - Italia 736
BR - Brasile 656
HK - Hong Kong 424
VN - Vietnam 378
DE - Germania 252
FI - Finlandia 160
NL - Olanda 127
GB - Regno Unito 106
IE - Irlanda 102
SE - Svezia 95
CA - Canada 92
UA - Ucraina 71
FR - Francia 68
CI - Costa d'Avorio 61
AR - Argentina 57
KR - Corea 49
MX - Messico 49
IN - India 47
BD - Bangladesh 39
ZA - Sudafrica 36
AT - Austria 30
ID - Indonesia 27
PL - Polonia 26
JP - Giappone 24
ES - Italia 23
TR - Turchia 19
EC - Ecuador 18
IQ - Iraq 14
CO - Colombia 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
PK - Pakistan 12
HU - Ungheria 11
IS - Islanda 11
MA - Marocco 11
BE - Belgio 10
IR - Iran 10
VE - Venezuela 9
LT - Lituania 7
UZ - Uzbekistan 7
BG - Bulgaria 6
EG - Egitto 6
AL - Albania 5
KE - Kenya 5
OM - Oman 5
PY - Paraguay 5
SA - Arabia Saudita 5
DO - Repubblica Dominicana 4
GE - Georgia 4
HN - Honduras 4
MY - Malesia 4
SI - Slovenia 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
GA - Gabon 3
IL - Israele 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
PE - Perù 3
RO - Romania 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BJ - Benin 2
BS - Bahamas 2
BW - Botswana 2
CH - Svizzera 2
GR - Grecia 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
MK - Macedonia 2
MN - Mongolia 2
NG - Nigeria 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TN - Tunisia 2
AD - Andorra 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
GF - Guiana Francese 1
GY - Guiana 1
Totale 12.776
Salva come PNG Salva come JPEG
Città #
Singapore 1.167
Moscow 441
Hong Kong 416
Beijing 359
Chandler 354
Hefei 270
Ashburn 230
Santa Clara 210
Millbury 145
Naples 137
Ho Chi Minh City 103
Los Angeles 102
Princeton 102
Amsterdam 96
Munich 90
Dong Ket 89
Nanjing 87
Wilmington 76
Des Moines 70
Redondo Beach 70
Jacksonville 67
Napoli 62
São Paulo 61
Buffalo 60
Hanoi 55
New York 55
Rome 53
Seattle 52
Boston 50
Seoul 48
Dallas 44
Norwalk 43
Turku 43
Helsinki 37
The Dalles 34
Ottawa 32
Houston 31
Nanchang 31
Brooklyn 28
Shenyang 28
Chicago 27
Falkenstein 26
Mexico City 24
Nuremberg 24
Montreal 23
Frankfurt am Main 22
Milan 22
Atlanta 20
Changsha 19
Jiaxing 19
Johannesburg 19
Rio de Janeiro 18
Biên Hòa 17
Hebei 17
Lawrence 17
Toronto 17
Da Nang 16
London 16
Tokyo 16
Warsaw 15
Denver 14
Orem 14
Stockholm 14
Woodbridge 14
Boardman 13
Haiphong 13
Poplar 13
Tianjin 13
Belo Horizonte 12
Dublin 12
Düsseldorf 12
Brasília 11
Curitiba 11
Dhaka 10
Falls Church 10
Lappeenranta 10
Reykjavík 10
San Francisco 10
Vienna 10
Brussels 9
Charlotte 9
Chennai 9
Phoenix 9
Porto Alegre 9
Shanghai 9
Ankara 8
Bari 8
Council Bluffs 8
Guarulhos 8
Hải Dương 8
Portici 8
Xi'an 8
Baghdad 7
Bexley 7
Genoa 7
Ninh Bình 7
Ortona 7
Querétaro 7
Quito 7
Salvador 7
Totale 6.314
Salva come PNG Salva come JPEG
Nome #
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice 136
Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia 134
Neuropsychiatric disorders in Cushing's syndrome. 134
M170. GENETIC CHARACTERIZATION OF A COHORT OF PATIENTS AFFECTED BY SCHIZOPHRENIA. THE ROLE FOR RARE STRUCTURAL VARIANTS IN MODULATING TREATMENT RESISTANT ENDOPHENOTYPES: PRELIMINARY DATA 127
Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine 124
D-aspartate dysregulation in Ddo-/- mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum 122
Psychological distress in serious mental illness patients during the COVID-19 outbreak and one-month mass quarantine in Italy 122
The effects of sustained COVID-19 emergency and restrictions on the mental health of subjects with serious mental illness: A prospective study 119
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs 117
The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment 116
Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling 114
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 113
The relationship between emotional regulation and eating behaviour: a multidimensional analysis of obesity psychopathology 113
Neural substrates of verbal memory impairment in schizophrenia: A multimodal connectomics study 108
Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings 106
Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia 106
Switching antipsychotics: Imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats 104
Alexithymia, suicidal ideation, and serum lipid levels among drug-na?ve outpatients with obsessive-compulsive disorder 103
Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients 103
Psychiatric Symptoms in Parkinson’s Disease Patients before and One Year after Subthalamic Nucleus Deep Brain Stimulation Therapy: Role of Lead Positioning and Not of Total Electrical Energy Delivered 102
Psychopathological Dimensions in Eating Disorders (E. D.) 102
Obsessive-Compulsive Aspects and Pathological Gambling in an Italian Sample 101
Nicotine and caffeine modulate haloperidol-induced changes in postsynaptic density transcripts expression: Translational insights in psychosis therapy and treatment resistance 101
Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action 100
Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders 100
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones 100
May second generation long-acting injectable antipsychotics be prescribed as a first-line treatment of first episode in patients with schizophrenia? An overview. 100
Cerebellar transcranial direct current stimulation in children with autism spectrum disorder: A pilot study on efficacy, feasibility, safety, and unexpected outcomes in tic disorder and epilepsy 100
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 99
Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables 99
Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants 99
Immediate-early genes modulation by antipsychotics: Translational implications for a putative gateway to drug-induced long-term brain changes 99
Depression and Anxiety Symptoms "Among the Waves" of the COVID-19 Pandemic in Obsessive Compulsive Disorder and Adjustment Disorder Patients 98
New advances in the treatment of generalized anxiety disorder: The multimodal antidepressant vortioxetine 98
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients 98
The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials 97
Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal 97
Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). 97
Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. 97
The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes 97
Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies beyond Dopamine Receptor Antagonism 97
Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients 97
Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression 97
Perinatal stress modulates glutamatergic functional connectivity: A post-synaptic density immediate early gene-based network analysis 96
Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study 96
Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole. 96
CHD2 mutations: Only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation 96
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study 96
Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients 95
MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective 95
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia 95
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia 94
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis 94
Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions 94
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 93
Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment 93
Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations 91
Clozapine's multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia 91
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia 91
Fisiopatologia cellulare e molecolare 91
Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches. 91
Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins 91
The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted 91
Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action 90
Striatal expression of Homer1a is affected by genotype but not dystonic phenotype of tottering mice: a model of spontaneously occurring motor disturbances 90
Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. 89
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review 88
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia 88
Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder 88
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia 88
Ketamine-related expression of glutamatergic postsynaptic density genes: possible implications in psychosis 87
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses 87
Modulation of glutamatergic functional connectivity by a prototypical antipsychotic: Translational inference from a postsynaptic density immediate-early gene-based network analysis 86
Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review 86
The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular “Lego” in the pathophysiology of psychiatric disorders. A systematic review and translational insight 86
C-reactive protein level and its relationship with suicide risk and alexithymia among newly diagnosed, drug-naïve patients with non-affective psychosis 85
Severity of autism-related symptoms in treatment-resistant schizophrenia: associations with cognitive performance, psychosocial functioning, and neurological soft signs - Clinical evidence and ROC analysis 84
Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA Study 84
Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysis “Nutra NMA SCZ” 84
Predicting the Severity of Lockdown-Induced Psychiatric Symptoms with Machine Learning 83
Residual effects of medications for sleep disorders on driving performance: A systematic review and network meta-analysis of randomized controlled trials 83
The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment 83
Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases 83
Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction 82
S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study. 82
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews 82
Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases 82
Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder 81
Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment 81
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders 81
Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: A systematic review 81
Corrigendum to “Exploring clinical phenotypes of food addiction and its distress correlates: A cross-sectional evaluation in treatment-seeking individuals with obesity” [Eating Behaviors volume 57 (April 2025), Online ahead of print, 101961] 80
Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia. 80
Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment 80
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 80
Efficacy and acceptability of pharmacological interventions for tardive dyskinesia in people with schizophrenia or mood disorders: a systematic review and network meta-analysis 79
Can the "connectomic way" provide a link between molecular neurobiology and phenomenological psychopathology? the case of schizophrenia 79
Cariprazine (RGH-188): A new pharmacological target option for the treatment of schizophrenia, bipolar disorders and depression? 79
Efficacia e sicurezza dell’asenapina in pazienti con episodi maniacali e misti associati a disturbo bipolare I 79
Impact of Benzodiazepines and Illness Duration on Obsessive–Compulsive Disorder during COVID-19 in Italy: Exploring Symptoms’ Evolutionary Benefits 78
Totale 9.551
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.925
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021267 0 0 0 0 0 56 26 10 45 18 19 93
2021/2022713 22 1 5 15 9 52 12 30 114 70 102 281
2022/2023888 128 70 26 56 113 132 5 88 130 69 57 14
2023/2024608 30 125 53 50 28 28 27 80 20 19 95 53
2024/20254.279 191 251 9 48 121 224 485 305 258 452 1.490 445
2025/20265.173 971 719 985 693 1.559 246 0 0 0 0 0 0
Totale 13.122